Geosearch / Live Stats / Bug Report / FAQ / About LinkedCT

Outcome: 83e43da42f70149da52f3e6859686d36 [RDF]

Label 83e43da42f70149da52f3e6859686d36
Slug 83e43da42f70149da52f3e6859686d36
Safety issue No
Measure Tumor Response
Description All eligible patients who received the first dose of Taxotere will be included in the analysis. Tumor Response will be categorized as: Complete Response (CR), Partial Response (PR), Stable Disease (SD), Progressive Disease (PD), Early Death from Malignant Disease. Per RECIST criteria, CR = disappearance of all target and nontarget lesions; PR = at least a 30% decrease in the sum of the largest diameter (LD) of target lesions taking as reference the baseline sum LD; SD = neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD taking as references the smallest sum LD since the treatment started; PD = at least a 20% increase in the sum of LD of target lesions taking as references the smallest sum LD recorded since the treatment started or the appearance of one or more new lesions.
Time frame 6 months after the last subject enrolled has gone off study
Provenances http://clinicaltrials.gov/show/NCT00184028?displayxml=true
Similars None
Interlinks None